# Utility of ICG in Benign Bone Tumors

> **NCT05075889** · EARLY_PHASE1 · COMPLETED · sponsor: **Dartmouth-Hitchcock Medical Center** · enrollment: 2 (actual)

## Conditions studied

- Bone Tumor

## Interventions

- **DRUG:** Indocyanine Green

## Key facts

- **NCT ID:** NCT05075889
- **Lead sponsor:** Dartmouth-Hitchcock Medical Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-11
- **Primary completion:** 2022-04-20
- **Final completion:** 2022-04-20
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2024-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05075889

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05075889, "Utility of ICG in Benign Bone Tumors". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT05075889. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*